ja_mageia

Neurofibromatosis Type 2 Meeting: The State of the Art
May 2-4, 2010
Bally's - Las Vegas, Nevada
Chairs: Dr. Derald Brackmann, Dr. Marco Giovannini, Dr. Robert Shannon
Sponsored by House Ear Institute
                                       

Despite the fact that significant progress has been made in the understanding of the biology of neurofibromatosis type 2 (NF2), patients with this disorder still face a poor clinical outcomes, significant morbidity and a decreased life span. The NF2 field is at a critical juncture and the goal of this conference is to provide a regular forum to bring together biologists, geneticists, clinicians, neurosurgeons, audiologists and others familiar with NF2 to share their latest basic and clinical research findings and experiences, with the ultimate goal to undertake international translational research projects and initiate NF2-specific targeted therapeutic trials.

Relevant questions to be discussed in this meeting are:
1. What Do We Know - and Don’t Know - About NF2 Biology?;
2. What is the natural history of NF2 tumors and its impact on clinical management?
3. Radiosurgery and Radiotherapy for NF2 Tumors?
4. What is the Satus of auditory rehabilitation in NF2 patients?
5. What is the Status of NF2 Preclinical Screening Tools?
6. What are Critical Endpoints in Evaluating NF2 Therapeutic Efficacy and Outcome?
7. What Are the Candidate Drugs and Potential Therapeutic Approaches for NF2?

In addition there will be a special function honoring the career and contributions of Dr. William Hitselberger to acoustic neuroma and auditory brainstem implant surgical techniques.

Please note that this meeting shares highly technical and confidential information, attendees are limited to
I) scientists & physicians who are focused on understanding or treating NF2 and
II) select invited experts from related fields.
 

This meeting is not intended for or open to laypersons.
This meeting is invitation ONLY and is not open to the general public!

Register Now!